25 XP   0   0   10

Avivagen Inc
Buy, Hold or Sell?

Let's analyse Avivagen together

PenkeI guess you are interested in Avivagen Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Avivagen Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Avivagen Inc

I send you an email if I find something interesting about Avivagen Inc.

Quick analysis of Avivagen (30 sec.)










What can you expect buying and holding a share of Avivagen? (30 sec.)

How much money do you get?

How much money do you get?
C$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
C$-0.12
Expected worth in 1 year
C$-0.17
How sure are you?
27.5%

+ What do you gain per year?

Total Gains per Share
C$-0.05
Return On Investment
-515.4%

For what price can you sell your share?

Current Price per Share
C$0.01
Expected price per share
C$0.01 - C$0.01
How sure are you?
50%

1. Valuation of Avivagen (5 min.)




Live pricePrice per Share (EOD)

C$0.01

Intrinsic Value Per Share

C$-0.21 - C$-0.04

Total Value Per Share

C$-0.33 - C$-0.15

2. Growth of Avivagen (5 min.)




Is Avivagen growing?

Current yearPrevious yearGrowGrow %
How rich?-$6.7m-$3.3m-$2.2m-39.5%

How much money is Avivagen making?

Current yearPrevious yearGrowGrow %
Making money-$847.7k-$1.1m$282.2k33.3%
Net Profit Margin-1,474.6%-1,586.5%--

How much money comes from the company's main activities?

3. Financial Health of Avivagen (5 min.)




What can you expect buying and holding a share of Avivagen? (5 min.)

Welcome investor! Avivagen's management wants to use your money to grow the business. In return you get a share of Avivagen.

What can you expect buying and holding a share of Avivagen?

First you should know what it really means to hold a share of Avivagen. And how you can make/lose money.

Speculation

The Price per Share of Avivagen is C$0.01. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Avivagen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Avivagen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is C$-0.12. Based on the TTM, the Book Value Change Per Share is C$-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is C$-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is C$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Avivagen.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 C$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per Share
Usd Eps-0.01-87.8%-0.01-101.8%-0.01-145.4%-0.01-125.1%-0.01-99.3%
Usd Book Value Change Per Share-0.01-90.0%-0.01-94.2%-0.01-62.8%0.00-49.1%0.00-13.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-90.0%-0.01-94.2%-0.01-62.8%0.00-49.1%0.00-13.8%
Usd Price Per Share0.01-0.05-0.19-0.29-0.25-
Price to Earnings Ratio-0.42--1.20--3.32--5.91--5.75-
Price-to-Total Gains Ratio-1.62--6.38--8.88--35.65--23.10-
Price to Book Ratio-0.17--0.84--4.48-13.29-19.46-
Price-to-Total Gains Ratio-1.62--6.38--8.88--35.65--23.10-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.007308
Number of shares136836
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (136836 shares)-1,288.54-671.80
Gains per Year (136836 shares)-5,154.16-2,687.18
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-5154-51640-2687-2697
20-10308-103180-5374-5384
30-15462-154720-8062-8071
40-20617-206260-10749-10758
50-25771-257800-13436-13445
60-30925-309340-16123-16132
70-36079-360880-18810-18819
80-41233-412420-21497-21506
90-46387-463960-24185-24193
100-51542-515500-26872-26880

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%1.064.00.01.5%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%3.017.00.015.0%11.029.00.027.5%17.047.01.026.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.065.00.0%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%3.017.00.015.0%11.029.00.027.5%17.047.01.026.2%

Fundamentals of Avivagen

About Avivagen Inc

Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.

Fundamental data was last updated by Penke on 2024-04-26 16:00:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Avivagen Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Avivagen earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Avivagen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -2,302.1% means that $-23.02 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Avivagen Inc:

  • The MRQ is -2,302.1%. The company is making a huge loss. -2
  • The TTM is -1,474.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-2,302.1%TTM-1,474.6%-827.5%
TTM-1,474.6%YOY-1,586.5%+111.9%
TTM-1,474.6%5Y-1,600.0%+125.5%
5Y-1,600.0%10Y-1,067.3%-532.7%
1.1.2. Return on Assets

Shows how efficient Avivagen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Avivagen to the Drug Manufacturers - Specialty & Generic industry mean.
  • -342.3% Return on Assets means that Avivagen generated $-3.42 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Avivagen Inc:

  • The MRQ is -342.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -256.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-342.3%TTM-256.1%-86.2%
TTM-256.1%YOY-65.0%-191.2%
TTM-256.1%5Y-93.0%-163.1%
5Y-93.0%10Y-66.6%-26.4%
1.1.3. Return on Equity

Shows how efficient Avivagen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Avivagen to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Equity means Avivagen generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Avivagen Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-82.2%+82.2%
5Y-82.2%10Y-75.0%-7.2%

1.2. Operating Efficiency of Avivagen Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Avivagen is operating .

  • Measures how much profit Avivagen makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Avivagen to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -1,025.3% means the company generated $-10.25  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Avivagen Inc:

  • The MRQ is -1,025.3%. The company is operating very inefficient. -2
  • The TTM is -665.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,025.3%TTM-665.4%-360.0%
TTM-665.4%YOY-1,096.9%+431.6%
TTM-665.4%5Y-1,138.7%+473.3%
5Y-1,138.7%10Y-1,267.0%+128.4%
1.2.2. Operating Ratio

Measures how efficient Avivagen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 11.20 means that the operating costs are $11.20 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Avivagen Inc:

  • The MRQ is 11.199. The company is inefficient in keeping operating costs low. -1
  • The TTM is 6.123. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ11.199TTM6.123+5.076
TTM6.123YOY13.270-7.148
TTM6.1235Y11.870-5.748
5Y11.87010Y9.702+2.168

1.3. Liquidity of Avivagen Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Avivagen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.03 means the company has $0.03 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Avivagen Inc:

  • The MRQ is 0.026. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.221. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.026TTM0.221-0.195
TTM0.221YOY0.786-0.565
TTM0.2215Y1.089-0.868
5Y1.08910Y4.180-3.091
1.3.2. Quick Ratio

Measures if Avivagen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Avivagen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.01 means the company can pay off $0.01 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Avivagen Inc:

  • The MRQ is 0.008. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.119. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.008TTM0.119-0.111
TTM0.119YOY0.381-0.263
TTM0.1195Y0.802-0.683
5Y0.80210Y3.886-3.084

1.4. Solvency of Avivagen Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Avivagen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Avivagen to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 35.00 means that Avivagen assets are financed with 3,499.8% credit (debt) and the remaining percentage (100% - 3,499.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Avivagen Inc:

  • The MRQ is 34.998. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 20.120. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ34.998TTM20.120+14.877
TTM20.120YOY2.936+17.184
TTM20.1205Y5.884+14.236
5Y5.88410Y4.019+1.866
1.4.2. Debt to Equity Ratio

Measures if Avivagen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Avivagen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Avivagen Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y1.608-1.608
5Y1.60810Y1.620-0.012

2. Market Valuation of Avivagen Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Avivagen generates.

  • Above 15 is considered overpriced but always compare Avivagen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -0.42 means the investor is paying $-0.42 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Avivagen Inc:

  • The EOD is -0.208. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.416. Based on the earnings, the company is expensive. -2
  • The TTM is -1.201. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.208MRQ-0.416+0.208
MRQ-0.416TTM-1.201+0.784
TTM-1.201YOY-3.317+2.116
TTM-1.2015Y-5.905+4.705
5Y-5.90510Y-5.747-0.159
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Avivagen Inc:

  • The EOD is 2.716. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 5.432. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -0.759. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD2.716MRQ5.432-2.716
MRQ5.432TTM-0.759+6.191
TTM-0.759YOY-6.098+5.339
TTM-0.7595Y-9.890+9.131
5Y-9.89010Y-7.954-1.936
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Avivagen is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Avivagen Inc:

  • The EOD is -0.084. Based on the equity, the company is expensive. -2
  • The MRQ is -0.168. Based on the equity, the company is expensive. -2
  • The TTM is -0.840. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.084MRQ-0.168+0.084
MRQ-0.168TTM-0.840+0.672
TTM-0.840YOY-4.482+3.642
TTM-0.8405Y13.292-14.132
5Y13.29210Y19.461-6.169
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Avivagen Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.012-0.013+5%-0.009-30%-0.007-45%-0.002-85%
Book Value Per Share---0.119-0.099-17%-0.060-50%-0.051-57%-0.033-73%
Current Ratio--0.0260.221-88%0.786-97%1.089-98%4.180-99%
Debt To Asset Ratio--34.99820.120+74%2.936+1092%5.884+495%4.019+771%
Debt To Equity Ratio----0%-0%1.608-100%1.620-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.012-0.014+16%-0.020+66%-0.017+43%-0.014+13%
Free Cash Flow Per Share--0.001-0.002+356%-0.012+1421%-0.010+1187%-0.010+1141%
Free Cash Flow To Equity Per Share--0.000-0.002+40265%-0.008+208370%-0.002+51282%0.000+2928%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.007-1%
Intrinsic Value_10Y_max---0.036--------
Intrinsic Value_10Y_min---0.208--------
Intrinsic Value_1Y_max---0.033--------
Intrinsic Value_1Y_min---0.036--------
Intrinsic Value_3Y_max---0.077--------
Intrinsic Value_3Y_min---0.095--------
Intrinsic Value_5Y_max---0.093--------
Intrinsic Value_5Y_min---0.140--------
Market Cap776947.040-100%1553894.0805632866.040-72%19812149.520-92%30883644.840-95%26425911.198-94%
Net Profit Margin---23.021-14.746-36%-15.865-31%-16.000-30%-10.673-54%
Operating Margin---10.253-6.654-35%-10.969+7%-11.387+11%-12.670+24%
Operating Ratio--11.1996.123+83%13.270-16%11.870-6%9.702+15%
Pb Ratio-0.084+50%-0.168-0.840+401%-4.482+2572%13.292-101%19.461-101%
Pe Ratio-0.208+50%-0.416-1.201+188%-3.317+697%-5.905+1318%-5.747+1280%
Price Per Share0.010-100%0.0200.073-72%0.255-92%0.398-95%0.340-94%
Price To Free Cash Flow Ratio2.716-100%5.432-0.759+114%-6.098+212%-9.890+282%-7.954+246%
Price To Total Gains Ratio-0.812+50%-1.624-6.378+293%-8.878+447%-35.652+2095%-23.096+1322%
Quick Ratio--0.0080.119-94%0.381-98%0.802-99%3.886-100%
Return On Assets---3.423-2.561-25%-0.650-81%-0.930-73%-0.666-81%
Return On Equity----0%-0%-0.8220%-0.7500%
Total Gains Per Share---0.012-0.013+5%-0.009-30%-0.007-45%-0.002-85%
Usd Book Value---6771165.282-5603036.475-17%-3392380.543-50%-2913377.025-57%-1845616.016-73%
Usd Book Value Change Per Share---0.009-0.009+5%-0.006-30%-0.005-45%-0.001-85%
Usd Book Value Per Share---0.087-0.072-17%-0.044-50%-0.037-57%-0.024-73%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.009-0.010+16%-0.015+66%-0.013+43%-0.010+13%
Usd Free Cash Flow--52262.431-134050.096+356%-690460.936+1421%-568268.618+1187%-543938.478+1141%
Usd Free Cash Flow Per Share--0.001-0.002+356%-0.009+1421%-0.007+1187%-0.007+1141%
Usd Free Cash Flow To Equity Per Share--0.000-0.001+40265%-0.006+208370%-0.001+51282%0.000+2928%
Usd Market Cap567792.897-100%1135585.7944116498.502-72%14478718.869-92%22569767.649-95%19312055.903-94%
Usd Price Per Share0.007-100%0.0150.053-72%0.186-92%0.290-95%0.249-94%
Usd Profit---681776.474-847709.913+24%-1129913.083+66%-983689.174+44%-780350.140+14%
Usd Revenue--29615.670130670.511-77%141904.004-79%179813.450-84%119535.969-75%
Usd Total Gains Per Share---0.009-0.009+5%-0.006-30%-0.005-45%-0.001-85%
 EOD+3 -5MRQTTM+14 -17YOY+12 -195Y+14 -1810Y+13 -20

3.2. Fundamental Score

Let's check the fundamental score of Avivagen Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.208
Price to Book Ratio (EOD)Between0-1-0.084
Net Profit Margin (MRQ)Greater than0-23.021
Operating Margin (MRQ)Greater than0-10.253
Quick Ratio (MRQ)Greater than10.008
Current Ratio (MRQ)Greater than10.026
Debt to Asset Ratio (MRQ)Less than134.998
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-3.423
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Avivagen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 500.010
Ma 50Greater thanMa 1000.010
Ma 100Greater thanMa 2000.010
OpenGreater thanClose0.010
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-07-312022-10-312023-01-312023-04-302023-07-31
Other Current Assets  34609422116-1898-980



Latest Balance Sheet

Balance Sheet of 2023-07-31. Currency in CAD. All numbers in thousands.

Summary
Total Assets273
Total Liabilities9,538
Total Stockholder Equity-9,265
 As reported
Total Liabilities 9,538
Total Stockholder Equity+ -9,265
Total Assets = 273

Assets

Total Assets273
Total Current Assets219
Long-term Assets53
Total Current Assets
Cash And Cash Equivalents 17
Net Receivables 48
Inventory 74
Total Current Assets  (as reported)219
Total Current Assets  (calculated)139
+/- 81
Long-term Assets
Property Plant Equipment 53
Long-term Assets  (as reported)53
Long-term Assets  (calculated)53
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities8,436
Long-term Liabilities1,102
Total Stockholder Equity-9,265
Total Current Liabilities
Short-term Debt 6,138
Short Long Term Debt 6,138
Accounts payable 790
Other Current Liabilities 64
Total Current Liabilities  (as reported)8,436
Total Current Liabilities  (calculated)13,131
+/- 4,695
Long-term Liabilities
Long term Debt 1,102
Long-term Liabilities  (as reported)1,102
Long-term Liabilities  (calculated)1,102
+/-0
Total Stockholder Equity
Common Stock34,920
Retained Earnings -47,432
Other Stockholders Equity 3,246
Total Stockholder Equity (as reported)-9,265
Total Stockholder Equity (calculated)-9,265
+/-0
Other
Capital Stock34,920
Cash and Short Term Investments 17
Common Stock Shares Outstanding 77,695
Current Deferred Revenue1,443
Liabilities and Stockholders Equity 273
Net Debt 7,224
Net Invested Capital -2,025
Net Tangible Assets -9,265
Net Working Capital -8,216
Property Plant and Equipment Gross 232
Short Long Term Debt Total 7,241



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2023-07-312023-04-302023-01-312022-10-312022-07-312022-04-302022-01-312021-10-312021-07-312021-04-302021-01-312020-10-312020-07-312020-04-302020-01-312019-10-312019-07-312019-04-302019-01-312018-10-312018-07-312018-04-302018-01-312017-10-312017-07-312017-04-302017-01-312016-10-312016-07-312016-04-302016-01-312015-10-312015-07-312015-04-302015-01-312014-10-312014-07-312014-04-302014-01-312013-10-312013-07-312013-04-302013-01-312012-10-312012-07-312012-04-302012-01-312011-10-312011-07-312011-04-302011-01-312010-10-312010-07-312010-04-302010-01-312009-10-312009-07-312009-04-302009-01-312008-10-312008-07-312008-04-302008-01-312007-10-312007-07-312007-01-31
> Total Assets 
0
0
750
874
774
719
614
572
802
461
1,488
859
559
1,062
1,264
1,106
1,568
990
361
490
315
382
395
265
328
431
1,402
2,048
1,833
1,367
869
1,927
1,457
1,056
693
1,126
684
3,463
5,196
5,546
4,449
2,995
1,850
4,541
3,589
3,629
3,109
2,119
3,797
2,598
1,888
3,959
2,671
2,571
2,176
1,425
5,985
4,865
3,478
2,544
3,014
1,660
1,365
568
325
273
2733255681,3651,6603,0142,5443,4784,8655,9851,4252,1762,5712,6713,9591,8882,5983,7972,1193,1093,6293,5894,5411,8502,9954,4495,5465,1963,4636841,1266931,0561,4571,9278691,3671,8332,0481,4024313282653953823154903619901,5681,1061,2641,0625598591,48846180257261471977487475000
   > Total Current Assets 
0
0
452
590
487
448
353
327
573
248
1,285
657
337
249
327
214
728
220
149
321
147
228
261
147
228
348
1,336
1,990
1,783
1,326
836
1,899
1,433
1,037
681
1,119
681
3,463
5,196
5,546
4,449
2,995
1,850
4,541
3,520
3,560
3,042
2,053
3,732
2,415
1,716
3,490
2,212
2,142
1,782
1,064
5,675
4,570
3,216
2,389
2,879
1,545
1,271
494
266
219
2192664941,2711,5452,8792,3893,2164,5705,6751,0641,7822,1422,2123,4901,7162,4153,7322,0533,0423,5603,5204,5411,8502,9954,4495,5465,1963,4636811,1196811,0371,4331,8998361,3261,7831,9901,3363482281472612281473211492207282143272493376571,28524857332735344848759045200
       Cash And Cash Equivalents 
0
0
385
521
407
342
228
215
357
171
507
582
237
84
72
24
488
69
59
75
21
53
184
66
153
279
1,046
1,817
1,570
1,255
769
1,829
1,386
987
632
1,050
634
3,369
5,142
5,467
4,349
2,692
1,600
4,126
3,070
3,003
2,207
1,437
3,225
1,879
1,086
2,679
1,521
1,242
664
475
4,246
2,948
1,408
818
1,465
495
290
27
17
17
1717272904951,4658181,4082,9484,2464756641,2421,5212,6791,0861,8793,2251,4372,2073,0033,0704,1261,6002,6924,3495,4675,1423,3696341,0506329871,3861,8297691,2551,5701,8171,04627915366184532175596948824728423758250717135721522834240752138500
       Net Receivables 
0
0
44
49
56
63
26
35
182
25
752
53
25
39
165
62
8
17
30
172
70
39
65
58
51
36
215
51
129
21
49
30
17
27
37
35
20
65
41
43
58
107
99
83
94
34
227
125
76
74
133
177
141
411
611
219
256
107
439
81
108
72
573
74
63
48
48637457372108814391072562196114111411771337476125227349483991075843416520353727173049211295121536515865397017230178621653925537522518235266356494400
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
76
88
207
116
46
17
10
39
0
11
11
0
0
102
68
34
0
22
15
7
10
33
26
18
11
35
28
169
60
61
89
66
29
59
44
68
46
211
185
144
101
125
245
221
137
239
335
34
94
116
98
0
0981169434335239137221245125101144185211466844592966896160169283511182633107152203468102001111039101746116207887600000000000000
   > Long-term Assets 
0
0
297
284
287
271
260
245
229
213
202
202
222
814
937
892
840
770
212
169
168
154
134
117
100
84
66
57
49
41
33
28
24
20
12
7
3
0
0
0
0
0
0
0
69
68
67
66
65
183
172
470
459
428
394
361
310
295
262
155
135
115
94
74
59
53
5359749411513515526229531036139442845947017218365666768690000000371220242833414957668410011713415416816921277084089293781422220220221322924526027128728429700
       Property Plant Equipment 
0
0
297
284
287
271
260
245
229
213
202
202
222
209
326
320
307
289
212
168
166
153
133
116
100
83
65
57
49
41
33
28
24
20
12
7
3
0
0
0
0
0
0
0
69
68
67
66
65
183
172
470
459
428
394
361
310
295
262
155
135
115
94
74
59
53
5359749411513515526229531036139442845947017218365666768690000000371220242833414957658310011613315316616821228930732032620922220220221322924526027128728429700
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
605
574
572
533
481
0
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000111111104815335725746050000000000000
> Total Liabilities 
0
0
769
769
1,018
1,104
1,761
1,972
2,574
2,580
2,590
2,348
2,673
3,316
3,727
3,626
4,356
4,212
4,682
4,369
4,616
4,626
4,615
4,939
3,404
3,820
3,331
3,222
3,185
3,212
3,261
3,431
3,397
3,423
3,518
4,342
4,464
4,835
4,796
4,845
5,142
4,780
1,681
1,871
1,815
2,455
3,015
3,084
4,932
4,921
5,144
5,725
5,628
6,167
6,944
7,477
7,163
7,457
7,430
8,005
6,907
6,921
7,349
7,678
8,633
9,538
9,5388,6337,6787,3496,9216,9078,0057,4307,4577,1637,4776,9446,1675,6285,7255,1444,9214,9323,0843,0152,4551,8151,8711,6814,7805,1424,8454,7964,8354,4644,3423,5183,4233,3973,4313,2613,2123,1853,2223,3313,8203,4044,9394,6154,6264,6164,3694,6824,2124,3563,6263,7273,3162,6732,3482,5902,5802,5741,9721,7611,1041,01876976900
   > Total Current Liabilities 
0
0
188
188
182
174
412
469
519
463
645
285
693
1,170
1,529
1,316
1,910
1,688
2,139
1,658
1,905
1,738
1,640
1,963
428
836
374
250
68
109
158
177
143
150
280
225
326
673
628
634
906
537
604
751
649
591
1,010
2,815
1,273
1,168
1,302
1,605
1,476
1,863
2,352
2,710
5,828
6,108
6,014
6,483
2,013
1,905
2,098
2,276
7,300
8,436
8,4367,3002,2762,0981,9052,0136,4836,0146,1085,8282,7102,3521,8631,4761,6051,3021,1681,2732,8151,010591649751604537906634628673326225280150143177158109682503748364281,9631,6401,7381,9051,6582,1391,6881,9101,3161,5291,17069328564546351946941217418218818800
       Short-term Debt 
0
0
0
0
0
0
0
0
0
12
25
4
341
350
366
0
0
0
0
0
5
0
699
859
0
0
0
0
0
0
0
0
0
0
0
71
93
111
147
75
76
77
78
79
106
210
247
1,955
760
712
746
875
867
943
1,538
1,957
5,161
5,191
5,390
5,574
808
783
835
1,003
5,437
6,138
6,1385,4371,0038357838085,5745,3905,1915,1611,9571,5389438678757467127601,9552472101067978777675147111937100000000000859699050000036635034142512000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,287
4,313
4,339
104
105
106
210
247
1,955
652
712
746
746
742
831
1,363
1,763
5,066
5,106
5,316
5,503
747
747
810
997
5,437
6,138
6,1385,4379978107477475,5035,3165,1065,0661,7631,3638317427467467126521,9552472101061051044,3394,3134,287000000000000000000000000000000000000000
       Accounts payable 
0
0
188
188
182
174
0
0
0
0
0
0
0
717
1,143
1,313
1,663
1,602
1,778
0
1,276
0
846
893
227
269
319
238
32
0
107
78
143
120
242
153
198
327
151
129
69
397
432
599
345
341
698
668
467
419
511
691
515
792
710
627
530
770
463
750
937
711
911
985
1,167
790
7901,167985911711937750463770530627710792515691511419467668698341345599432397691291513271981532421201437810703223831926922789384601,27601,7781,6021,6631,3131,143717000000017418218818800
       Other Current Liabilities 
0
0
0
0
0
0
251
333
409
364
617
278
349
817
33
0
244
83
358
1,655
621
1,735
780
1,057
201
567
55
12
37
109
51
99
0
30
38
0
36
235
330
430
761
62
94
73
198
39
65
191
46
37
45
40
94
127
104
126
137
147
160
159
64
64
64
64
64
64
646464646464159160147137126104127944045374619165391987394627614303302353603830099511093712555672011,0577801,7356211,65535883244033817349278617364409333251000000
   > Long-term Liabilities 
0
0
581
581
836
930
1,349
1,503
2,056
2,117
1,945
2,063
1,979
2,145
2,198
2,310
2,446
2,524
2,543
2,711
2,711
2,888
2,976
2,976
2,976
2,984
2,958
2,972
3,117
3,103
3,103
3,254
3,254
3,274
3,238
4,118
4,138
4,163
4,167
4,211
4,236
4,243
1,077
1,120
1,165
1,864
2,005
269
3,659
3,753
3,842
4,120
4,153
4,304
4,592
4,767
1,335
1,349
1,417
1,522
4,894
5,016
5,251
5,403
1,334
1,102
1,1021,3345,4035,2515,0164,8941,5221,4171,3491,3354,7674,5924,3044,1534,1203,8423,7533,6592692,0051,8641,1651,1201,0774,2434,2364,2114,1674,1634,1384,1183,2383,2743,2543,2543,1033,1033,1172,9722,9582,9842,9762,9762,9762,8882,7112,7112,5432,5242,4462,3102,1982,1451,9792,0631,9452,1172,0561,5031,34993083658158100
> Total Stockholder Equity
0
0
-19
106
-244
-385
-1,148
-1,400
-1,772
-2,119
-1,102
-1,489
-2,114
-2,253
-2,463
-2,520
-2,788
-3,223
-4,321
-3,878
-4,301
-4,245
-4,220
-4,674
-3,076
-3,388
-1,930
-1,174
-1,353
-1,845
-2,392
-1,504
-1,940
-2,367
-2,825
-3,216
-3,780
-1,373
401
701
-693
-1,785
169
2,670
1,775
1,174
94
-965
-1,135
-2,324
-3,256
-1,766
-2,957
-3,596
-4,768
-6,052
-1,178
-2,592
-3,953
-5,461
-3,894
-5,261
-5,984
-7,110
-8,309
-9,265
-9,265-8,309-7,110-5,984-5,261-3,894-5,461-3,953-2,592-1,178-6,052-4,768-3,596-2,957-1,766-3,256-2,324-1,135-965941,1741,7752,670169-1,785-693701401-1,373-3,780-3,216-2,825-2,367-1,940-1,504-2,392-1,845-1,353-1,174-1,930-3,388-3,076-4,674-4,220-4,245-4,301-3,878-4,321-3,223-2,788-2,520-2,463-2,253-2,114-1,489-1,102-2,119-1,772-1,400-1,148-385-244106-1900
   Common Stock
0
0
0
0
0
0
0
3,884
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,794
19,813
19,898
19,910
22,561
22,609
22,880
22,964
22,964
23,957
23,957
23,957
26,398
26,505
26,505
26,555
26,490
31,823
31,823
31,823
31,823
34,052
34,364
34,895
34,895
34,925
34,920
34,92034,92534,89534,89534,36434,05231,82331,82331,82331,82326,49026,55526,50526,50526,39823,95723,95723,95722,96422,96422,88022,60922,56119,91019,89819,81319,79400000000000000000000000000000003,8840000000
   Retained Earnings Total Equity000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
250
250
250
250
350
0
0
50
0
0
0
0
0
0
0
0
0
0
0
0
00000000000050003502502502502500000000000000000000000000000000000000000000000
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
4,335
4,360
4,389
4,420
4,475
645
4,660
4,714
5,865
6,190
6,252
6,803
7,283
7,954
8,594
8,910
8,935
10,096
10,138
10,659
11,010
11,107
13,196
13,340
15,325
16,541
16,828
16,888
16,943
18,362
18,388
18,452
18,514
15,684
15,656
18,557
21,114
22,335
22,350
22,514
22,623
26,366
3,131
3,282
3,276
26,307
3,445
3,359
3,450
3,662
3,757
3,818
3,814
3,861
5,288
4,631
4,697
3,848
4,353
4,408
4,315
4,343
3,233
3,246
3,2463,2334,3434,3154,4084,3533,8484,6974,6315,2883,8613,8143,8183,7573,6623,4503,3593,44526,3073,2763,2823,13126,36622,62322,51422,35022,33521,11418,55715,65615,68418,51418,45218,38818,36216,94316,88816,82816,54115,32513,34013,19611,10711,01010,65910,13810,0968,9358,9108,5947,9547,2836,8036,2526,1905,8654,7144,6606454,4754,4204,3894,3604,33500



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2022-10-31)

Gross Profit (+$)
totalRevenue939
Cost of Revenue-539
Gross Profit400400
 
Operating Income (+$)
Gross Profit400
Operating Expense-1,934
Operating Income-934-1,534
 
Operating Expense (+$)
Research Development0
Selling General Administrative1,897
Selling And Marketing Expenses0
Operating Expense1,9341,897
 
Net Interest Income (+$)
Interest Income1
Interest Expense-1,769
Other Finance Cost-599
Net Interest Income-1,168
 
Pretax Income (+$)
Operating Income-934
Net Interest Income-1,168
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-6,0662,431
EBIT - interestExpense = -2,702
-4,298
-4,298
Interest Expense1,769
Earnings Before Interest and Taxes (EBIT)-934-4,298
Earnings Before Interest and Taxes (EBITDA)-846
 
After tax Income (+$)
Income Before Tax-6,066
Tax Provision-0
Net Income From Continuing Ops-6,066-6,066
Net Income-6,066
Net Income Applicable To Common Shares-6,066
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses2,473
Total Other Income/Expenses Net-3,3641,168
 

Technical Analysis of Avivagen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Avivagen. The general trend of Avivagen is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Avivagen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Avivagen Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.01 < 0.01 < 0.01.

The bearish price targets are: 0.01 > 0.01 > 0.01.

Tweet this
Avivagen Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Avivagen Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Avivagen Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Avivagen Inc. The current macd is 0.0000.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Avivagen price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Avivagen. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Avivagen price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Avivagen Inc Daily Moving Average Convergence/Divergence (MACD) ChartAvivagen Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Avivagen Inc. The current adx is 11.49.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Avivagen shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Avivagen Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Avivagen Inc. The current sar is 0.01038672.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Avivagen Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Avivagen Inc. The current rsi is 0. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Avivagen Inc Daily Relative Strength Index (RSI) ChartAvivagen Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Avivagen Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Avivagen price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Avivagen Inc Daily Stochastic Oscillator ChartAvivagen Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Avivagen Inc. The current cci is -66.66666667.

Avivagen Inc Daily Commodity Channel Index (CCI) ChartAvivagen Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Avivagen Inc. The current cmo is 0.

Avivagen Inc Daily Chande Momentum Oscillator (CMO) ChartAvivagen Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Avivagen Inc. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Avivagen Inc Daily Williams %R ChartAvivagen Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Avivagen Inc.

Avivagen Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Avivagen Inc. The current atr is 0.0000.

Avivagen Inc Daily Average True Range (ATR) ChartAvivagen Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Avivagen Inc. The current obv is 494,900.

Avivagen Inc Daily On-Balance Volume (OBV) ChartAvivagen Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Avivagen Inc. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Avivagen Inc Daily Money Flow Index (MFI) ChartAvivagen Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Avivagen Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-04-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.

6.3. Candlestick Patterns

Avivagen Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Avivagen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 500.010
Ma 50Greater thanMa 1000.010
Ma 100Greater thanMa 2000.010
OpenGreater thanClose0.010
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Avivagen with someone you think should read this too:
  • Are you bullish or bearish on Avivagen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Avivagen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Avivagen Inc

I send you an email if I find something interesting about Avivagen Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Avivagen Inc.

Receive notifications about Avivagen Inc in your mailbox!